Wednesday, July 8, 2026

Drug profile · INN

manganese chloride tetrahydrate

manganese chloride tetrahydrate (LUMENHANCE) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 2
News articles 0
Drug details — manganese chloride tetrahydrate
US status
approved
Class
Route
ORAL
Patents
0
Programs
2
Data quality
0.84

Quick answer

manganese chloride tetrahydrate (LUMENHANCE) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN manganese chloride tetrahydrate
Brand LUMENHANCE
Route ORAL
Formulation FOR SOLUTION

Approval history

Authority Status Date
FDA approved

Pipeline programs

  1. ENHANCE Phase 2 · George Institute for · Intermediate risk prostate cancer
  2. Minocycline Unknown · First People's Hospital · Intracerebral Hemorrhage

Frequently asked questions

What is manganese chloride tetrahydrate?

manganese chloride tetrahydrate (LUMENHANCE) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for manganese chloride tetrahydrate?

LUMENHANCE is a marketed brand name for manganese chloride tetrahydrate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of manganese chloride tetrahydrate?

manganese chloride tetrahydrate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.